secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001628908-23-000180
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health proposes $350M convertible notes due 2029 to pay down term loan
------------------------------------------------------------------------------

- Offering $350M aggregate principal of convertible senior notes due 2029; underwriters may purchase up to $52.5M additional.
- Notes convertible into cash, EVH Class A common stock, or a combination at company's election; conversion rate and interest rate set at pricing.
- Proceeds plus available liquidity used to prepay outstanding borrowings under its term loan facility (maturing Jan 2029).
- Interest on notes payable semiannually starting June 1, 2024; notes mature December 1, 2029 unless earlier repurchased or converted.
- Offering exempt from registration under Securities Act, sold only to qualified institutional buyers via Rule 144A.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000180/0001628908-23-000180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000180/evh-20231205.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer